Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C vaginal sustained-release tablets for bacterial vaginosis
CTR20130212Phase 2Active
- Sponsor
- Shenyang Huatai Pharmaceutical Research
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ascorbic acid in bacterial vaginosis (BV) (2 arms), sponsored by Shenyang Huatai Pharmaceutical Research. Primary endpoint: Post-treatment recurrence rate. Started Jan 2015; status: active.
02
Drugs
ascorbic acid
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on CTR20130212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130212.